GenePOC
2007
FOUNDED
M&A
STATUS
91-100
EMPLOYEES
M&A
LATEST DEAL TYPE
$120M
LATEST DEAL AMOUNT
Description
Developer of a molecular diagnostics testing device designed to speed up the diagnostic process. The company's device is a portable instrument for the prevention and early detection of infectious diseases based on unique centripetal technology services, enabling healthcare professionals and patients to get affordable, simple, and rapid Point of Care (POC) molecular diagnostic tests for infectious diseases.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Parent Company
Primary Office
- 360 rue Franquet, porte 3
- Québec, Quebec G1P 4N3
- Canada
+1 (418) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore GenePOC’s full profile, request a free trial.
GenePOC Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 03-Jun-2019 | $120M | 00000 | Completed | Generating Revenue | |
| 2. Merger/Acquisition | 30-Aug-2016 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 13-Jan-2015 | Completed | Generating Revenue |
GenePOC Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| STAT-Dx | Formerly VC-backed | Barcelona, Spain | 000.00 | 000000&0 | 000.00 | |
| 0000000 0000000 00 | Formerly VC-backed | Yokneam Ilit, Israel | 000.00 | 0000000000 | ||
| 00000000 | Venture Capital-Backed | Redwood City, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 | Corporation | San Diego, CA | 0000 | |||
| 0000000000000 | Venture Capital-Backed | Leuven, Belgium | 000.00 | 00000000000 | 000.00 |
GenePOC Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| CM-CIC Investissement | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Debiopharm Group | Corporation | Majority | 000 0000 | 000000 0 | ||
| Emerillon Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
GenePOC Executive Team (9)
1 Former Executive
You’re viewing 5 of 9 executives. Get the full list »GenePOC Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Chuck Morrison | GenePOC | Board Member | 000 0000 | |
| Denis Robichon Ph.D | GenePOC | Board Member | 000 0000 | |
| Jeremy Bridge-Cook Ph.D | Self | Board Member | 000 0000 | |
| Tanja Dowe | Self | Chairman | 000 0000 |
4 Former Board Members
You’re viewing 4 of 8 board members. Get the full list »